SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Schrodinger, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$23.12+0.52 (+2.30%)

Close on Oct 19, 2026

Market cap: $1.75B
P/E (TTM): –
Dividend yield: –

Schrodinger, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31
Revenue	59	59	87	54	55	60	88	35	47	37	74	43	35	65	57	37	38	49	46	30	30	32	33	26	23	26	26	20	19	21
Cost of Revenue	26	29	30	26	29	28	24	18	16	18	17	19	21	19	18	20	21	21	20	19	18	16	14	11	9.51	11	10	9.25	9.16	7.74
Gross Profit	32	30	57	28	26	31	64	18	31	19	58	24	14	46	39	17	17	28	26	11	12	16	19	15	14	16	16	11	9.85	13
Research & Development	41	44	41	43	43	46	49	51	51	51	51	47	43	41	35	33	31	28	25	23	21	21	17	17	17	14	11	10	9.53	8.44
Selling, General & Admin	33	35	33	31	36	36	35	35	33	36	36	33	32	35	33	30	29	29	24	23	21	19	18	14	14	14	12	12	14	10
Selling & Marketing	10	12	10	9.52	11	10	9.70	10	9.69	10	9.95	9.11	9.02	9.15	9.38	7.16	7.43	6.67	5.98	5.56	5.38	5.24	4.68	3.97	4.36	4.79	5.74	5.19	5.34	5.09
General & Administrative	23	23	23	22	25	26	26	25	24	26	26	24	23	26	23	23	22	22	18	17	16	13	14	9.73	9.65	8.94	6.55	6.47	8.94	5.09
Operating Expenses	74	78	74	74	79	82	85	86	84	86	87	80	75	76	67	63	61	57	49	46	42	40	36	31	31	27	23	22	24	19
Operating Income	-42	-49	-17	-46	-53	-51	-21	-68	-53	-67	-30	-56	-61	-31	-29	-46	-43	-29	-23	-35	-30	-24	-17	-15	-17	-12	-7.85	-11	-14	-5.61
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.33	-0.01	0.29	0.36	0.42	0.52	0.46	0.57	0.70	0.42	0.50	0.52	0.44
Income from Equity Investments	–	–	0	0	0	0	0	0	0	0	-0.11	0	0	147	0	0.00	12	0	0	0	0	-1.78	-0.05	0	4.16	–	–	–	–	–
Other Non-Operating Income	49	-11	50	13	10	-8.89	-19	30	-1.24	13	-1.89	-8.72	45	186	1.20	6.50	-4.18	-5.83	-7.93	-0.34	-4.56	23	5.22	19	13	-2.38	0.67	-0.93	13	-0.19
Gain (Loss) on Investments	46	-13	47	9.69	4.58	-13	-22	25	-5.83	8.14	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0.01	-0.01	0	0	-0.02	0	0	0.00	–	–	0.00	-0.08	-0.06	0	-0.01	-0.02	0	0.00	0	-0.12	0	-0.02	–	–	–	–	–	–	–	–
Pretax Income	7.35	-60	33	-33	-43	-60	-39	-38	-54	-54	-32	-65	-16	155	-27	-40	-48	-34	-30	-35	-35	-0.45	-11	3.25	-4.00	-14	-7.17	-12	-0.78	-5.80
Income Tax Expense	1.37	0.41	0.46	0.16	0.29	0.03	0.96	-0.09	0.08	0.46	-0.84	-2.89	-20	26	-0.14	0.19	0.03	-0.03	0.27	0.00	0.07	0.07	0.23	-0.04	0.06	0.09	-0.03	-0.26	-0.05	0.05
Net Income incl. Noncontrolling Interests	5.98	-60	33	-33	-43	-60	-40	-38	-54	-55	-31	-62	4.28	129	-27	-40	-48	-34	-31	-35	-35	-0.52	-12	3.29	-4.07	-14	-7.15	-12	-0.73	-5.85
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	0.00	0.01	-0.01	0.00	0.00	-0.33	-0.49	-0.45	-0.57	-0.72	-0.45	-0.38	-0.45	-0.23	-0.05
Net Income	5.98	-60	33	-33	-43	-60	-40	-38	-54	-55	-31	-62	4.28	129	-27	-40	-48	-34	-31	-35	-35	-0.03	-11	3.85	-3.35	-14	-6.77	-12	-0.50	-5.79
EPS (Basic)(per share)	0.08	-0.81	0.44	-0.45	-0.59	-0.82	-0.55	-0.52	-0.74	-0.76	-0.43	-0.86	0.06	1.81	-0.38	-0.56	-0.67	-0.48	-0.43	-0.49	-0.49	0.00	-0.16	0.06	-0.05	-0.34	–	-0.26	-0.01	-0.98
EPS (Diluted)(per share)	0.08	-0.81	0.44	-0.45	-0.59	-0.82	-0.55	-0.52	-0.74	-0.76	-0.41	-0.86	0.06	1.75	-0.38	-0.56	-0.67	-0.48	-0.43	-0.49	-0.49	0.00	-0.16	0.05	-0.05	-0.34	–	-0.26	-0.01	-0.98
Shares Outstanding (Basic, Weighted)(shares)	75	74	74	74	73	73	73	73	73	72	72	72	72	71	71	71	71	71	71	71	71	70	70	66	63	41	–	45	44	5.94
Shares Outstanding (Diluted, Weighted)(shares)	76	74	74	74	73	73	73	73	73	72	75	72	75	74	71	71	71	71	71	71	71	70	70	73	63	41	–	45	44	5.94
EBITDA	-40	-47	-16	-44	-51	-49	-19	-67	-51	-66	-28	-55	-60	-29	-27	-45	-42	-28	-22	-34	-30	-23	-16	-15	-16	-11	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 56.9%
Operating margin: -59.2%
Net margin: -21.0%
Return on equity, FY2025: -26.3%

Financial strength

Current ratio: 2.71
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 165.6%

Valuation

P/E ratio: –
Price to sales: 6.76
Price to book: 5.33
Dividend yield: –